Emerging biomedical imaging-based companion diagnostics for precision medicine

Summary: The tumor heterogeneity, which leads to individual variations in tumor microenvironments, causes poor prognoses and limits therapeutic response. Emerging technology such as companion diagnostics (CDx) detects biomarkers and monitors therapeutic responses, allowing identification of patients...

Full description

Bibliographic Details
Main Authors: Shiyi Liao, Mengjie Zhou, Youjuan Wang, Chang Lu, Baoli Yin, Ying Zhang, Huiyi Liu, Xia Yin, Guosheng Song
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223013548
_version_ 1797780002173878272
author Shiyi Liao
Mengjie Zhou
Youjuan Wang
Chang Lu
Baoli Yin
Ying Zhang
Huiyi Liu
Xia Yin
Guosheng Song
author_facet Shiyi Liao
Mengjie Zhou
Youjuan Wang
Chang Lu
Baoli Yin
Ying Zhang
Huiyi Liu
Xia Yin
Guosheng Song
author_sort Shiyi Liao
collection DOAJ
description Summary: The tumor heterogeneity, which leads to individual variations in tumor microenvironments, causes poor prognoses and limits therapeutic response. Emerging technology such as companion diagnostics (CDx) detects biomarkers and monitors therapeutic responses, allowing identification of patients who would benefit most from treatment. However, currently, most US Food and Drug Administration-approved CDx tests are designed to detect biomarkers in vitro and ex vivo, making it difficult to dynamically report variations of targets in vivo. Various medical imaging techniques offer dynamic measurement of tumor heterogeneity and treatment response, complementing CDx tests. Imaging-based companion diagnostics allow for patient stratification for targeted medicines and identification of patient populations benefiting from alternative therapeutic methods. This review summarizes recent developments in molecular imaging for predicting and assessing responses to cancer therapies, as well as the various biomarkers used in imaging-based CDx tests. We hope this review provides informative insights into imaging-based companion diagnostics and advances precision medicine.
first_indexed 2024-03-12T23:38:29Z
format Article
id doaj.art-2813c24dc9924f8c8063e7ef30163e26
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-12T23:38:29Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-2813c24dc9924f8c8063e7ef30163e262023-07-15T04:29:07ZengElsevieriScience2589-00422023-08-01268107277Emerging biomedical imaging-based companion diagnostics for precision medicineShiyi Liao0Mengjie Zhou1Youjuan Wang2Chang Lu3Baoli Yin4Ying Zhang5Huiyi Liu6Xia Yin7Guosheng Song8State Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, ChinaState Key Laboratory for Chemo, Biosensing and Chemometrics, College of Chemistry and Chemical, Engineering, Hunan University, Changsha 410082, China; Corresponding authorSummary: The tumor heterogeneity, which leads to individual variations in tumor microenvironments, causes poor prognoses and limits therapeutic response. Emerging technology such as companion diagnostics (CDx) detects biomarkers and monitors therapeutic responses, allowing identification of patients who would benefit most from treatment. However, currently, most US Food and Drug Administration-approved CDx tests are designed to detect biomarkers in vitro and ex vivo, making it difficult to dynamically report variations of targets in vivo. Various medical imaging techniques offer dynamic measurement of tumor heterogeneity and treatment response, complementing CDx tests. Imaging-based companion diagnostics allow for patient stratification for targeted medicines and identification of patient populations benefiting from alternative therapeutic methods. This review summarizes recent developments in molecular imaging for predicting and assessing responses to cancer therapies, as well as the various biomarkers used in imaging-based CDx tests. We hope this review provides informative insights into imaging-based companion diagnostics and advances precision medicine.http://www.sciencedirect.com/science/article/pii/S2589004223013548DiagnosticsBiomedical engineering
spellingShingle Shiyi Liao
Mengjie Zhou
Youjuan Wang
Chang Lu
Baoli Yin
Ying Zhang
Huiyi Liu
Xia Yin
Guosheng Song
Emerging biomedical imaging-based companion diagnostics for precision medicine
iScience
Diagnostics
Biomedical engineering
title Emerging biomedical imaging-based companion diagnostics for precision medicine
title_full Emerging biomedical imaging-based companion diagnostics for precision medicine
title_fullStr Emerging biomedical imaging-based companion diagnostics for precision medicine
title_full_unstemmed Emerging biomedical imaging-based companion diagnostics for precision medicine
title_short Emerging biomedical imaging-based companion diagnostics for precision medicine
title_sort emerging biomedical imaging based companion diagnostics for precision medicine
topic Diagnostics
Biomedical engineering
url http://www.sciencedirect.com/science/article/pii/S2589004223013548
work_keys_str_mv AT shiyiliao emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT mengjiezhou emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT youjuanwang emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT changlu emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT baoliyin emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT yingzhang emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT huiyiliu emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT xiayin emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine
AT guoshengsong emergingbiomedicalimagingbasedcompaniondiagnosticsforprecisionmedicine